Cometriq

Cabozantinib S-Malate

8.5 High risk

Cometriq & Off label use

18.1%

of users reported Off label use

57.5%

also reported Death

63.0%

are men

Most common medical consequences

Death
57.5%
Hospitalization
29.3%
Severe reaction
12.1%
Life-threatening condition
1.1%

Have you experienced any negative side effects from this medication?

Cometriq: general information

Most common side effects (56)

Most commonly affected ages

30 - 39 years
1.2%
40 - 49 years
9.6%
50 - 59 years
28.1%
60 - 69 years
31.9%
70 - 79 years
25.6%
80 - 89 years
3.6%